Cinnamaldehyde, an activator of Nrf2, can be used to improve metabolic profile, and to revert endothelial dysfunction in obesity and metabolic syndrome. This evidence concerns the gene NFE2L2 and obesity due to melanocortin 4 receptor deficiency.